Bausch & Lomb: SAC Capital/Steven A. Cohen Discloses 5.5% Stake

| About: Valeant Pharmaceuticals (VRX)

In a 13D filing after the close on Bausch & Lomb Inc. (NYSE: BOL), SAC Capital / Steven A. Cohen disclosed a 5.5% stake (2,989,995 shares) in the company. The firm held 33,800 BOL shares at tHe quarter ended March 31, 2007.

In a boilerplate disclosure, SAC said they intend to monitor the investment and may seek discussions with management or the board in the future.

Late Thursday, Advanced Medical Optics (NYSE: EYE) announced a $75 per share offer for Bausch & Lomb, topping a $65 bid from private equity firm Warburg Pincus.

BOL 1-yr chart

BOL